APO Research
Talk to an analyst

APO RESEARCH · REPORT

Severe Asthma Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Severe Asthma Treatment Industry Research Report 2026

22 December 2025125 pages

Choose your research edition.

Industry ResearchSevere Asthma Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Severe Asthma Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Severe Asthma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Severe Asthma Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Severe Asthma Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Severe Asthma Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Severe Asthma Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Severe Asthma Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Severe Asthma Treatment include Teva Pharmaceutical, Suzhou Connect Biopharmaceuticals, Sanofi, Novartis, Roche, GlaxoSmithKline, AstraZeneca, Regeneron Pharmaceutical and Pieris Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Severe Asthma Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Severe Asthma Treatment Market by Company

Teva Pharmaceutical

Suzhou Connect Biopharmaceuticals

Sanofi

Novartis

Roche

GlaxoSmithKline

AstraZeneca

Regeneron Pharmaceutical

Pieris Pharma

Morphosys

Biosion

Avalo Therapeutics

AB Pharma

4D Pharma plc

Severe Asthma Treatment Segment by Type

lntravenous

Oral

Subcutaneous

lnhaled

Severe Asthma Treatment Segment by Application

Teenagers

Children

Adults

Severe Asthma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Severe Asthma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Severe Asthma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Severe Asthma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Severe Asthma Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Severe Asthma Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Severe Asthma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Severe Asthma Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Severe Asthma Treatment Sales (k units) of Manufacturers (2021-2026) Table 7. Global Severe Asthma Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Severe Asthma Treatment Revenue of Manufacturers (2021-2026) Table 9. Global Severe Asthma Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Severe Asthma Treatment Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Severe Asthma Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Severe Asthma Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Severe Asthma Treatment, Product Type & Application Table 14. Global Severe Asthma Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Severe Asthma Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Company Information Table 19. Teva Pharmaceutical Business Overview Table 20. Teva Pharmaceutical Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Severe Asthma Treatment Product Portfolio Table 22. Teva Pharmaceutical Recent Developments Table 23. Suzhou Connect Biopharmaceuticals Company Information Table 24. Suzhou Connect Biopharmaceuticals Business Overview Table 25. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio Table 27. Suzhou Connect Biopharmaceuticals Recent Developments Table 28. Sanofi Company Information Table 29. Sanofi Business Overview Table 30. Sanofi Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Sanofi Severe Asthma Treatment Product Portfolio Table 32. Sanofi Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Novartis Severe Asthma Treatment Product Portfolio Table 37. Novartis Recent Developments Table 38. Roche Company Information Table 39. Roche Business Overview Table 40. Roche Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Roche Severe Asthma Treatment Product Portfolio Table 42. Roche Recent Developments Table 43. GlaxoSmithKline Company Information Table 44. GlaxoSmithKline Business Overview Table 45. GlaxoSmithKline Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline Severe Asthma Treatment Product Portfolio Table 47. GlaxoSmithKline Recent Developments Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. AstraZeneca Severe Asthma Treatment Product Portfolio Table 52. AstraZeneca Recent Developments Table 53. Regeneron Pharmaceutical Company Information Table 54. Regeneron Pharmaceutical Business Overview Table 55. Regeneron Pharmaceutical Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio Table 57. Regeneron Pharmaceutical Recent Developments Table 58. Pieris Pharma Company Information Table 59. Pieris Pharma Business Overview Table 60. Pieris Pharma Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Pieris Pharma Severe Asthma Treatment Product Portfolio Table 62. Pieris Pharma Recent Developments Table 63. Morphosys Company Information Table 64. Morphosys Business Overview Table 65. Morphosys Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Morphosys Severe Asthma Treatment Product Portfolio Table 67. Morphosys Recent Developments Table 68. Biosion Company Information Table 69. Biosion Business Overview Table 70. Biosion Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Biosion Severe Asthma Treatment Product Portfolio Table 72. Biosion Recent Developments Table 73. Avalo Therapeutics Company Information Table 74. Avalo Therapeutics Business Overview Table 75. Avalo Therapeutics Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Avalo Therapeutics Severe Asthma Treatment Product Portfolio Table 77. Avalo Therapeutics Recent Developments Table 78. AB Pharma Company Information Table 79. AB Pharma Business Overview Table 80. AB Pharma Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. AB Pharma Severe Asthma Treatment Product Portfolio Table 82. AB Pharma Recent Developments Table 83. 4D Pharma plc Company Information Table 84. 4D Pharma plc Business Overview Table 85. 4D Pharma plc Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. 4D Pharma plc Severe Asthma Treatment Product Portfolio Table 87. 4D Pharma plc Recent Developments Table 88. Global Severe Asthma Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Severe Asthma Treatment Sales by Region (2021-2026) & (k units) Table 90. Global Severe Asthma Treatment Sales Market Share by Region (2021-2026) Table 91. Global Severe Asthma Treatment Sales by Region (2027-2032) & (k units) Table 92. Global Severe Asthma Treatment Sales Market Share by Region (2027-2032) Table 93. Global Severe Asthma Treatment Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Severe Asthma Treatment Revenue Market Share by Region (2021-2026) Table 95. Global Severe Asthma Treatment Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Severe Asthma Treatment Revenue Market Share by Region (2027-2032) Table 97. North America Severe Asthma Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 99. North America Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 100. North America Severe Asthma Treatment Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Severe Asthma Treatment Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Severe Asthma Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 104. Europe Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 105. Europe Severe Asthma Treatment Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Severe Asthma Treatment Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Severe Asthma Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Severe Asthma Treatment Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Severe Asthma Treatment Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Severe Asthma Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 114. South America Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 115. South America Severe Asthma Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Severe Asthma Treatment Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Severe Asthma Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Severe Asthma Treatment Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Severe Asthma Treatment Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 123. Global Severe Asthma Treatment Sales by Type (2027-2032) & (k units) Table 124. Global Severe Asthma Treatment Sales Market Share by Type (2021-2026) Table 125. Global Severe Asthma Treatment Sales Market Share by Type (2027-2032) Table 126. Global Severe Asthma Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Severe Asthma Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Severe Asthma Treatment Revenue Market Share by Type (2021-2026) Table 129. Global Severe Asthma Treatment Revenue Market Share by Type (2027-2032) Table 130. Global Severe Asthma Treatment Price by Type (2021-2026) & (US$/unit) Table 131. Global Severe Asthma Treatment Price by Type (2027-2032) & (US$/unit) Table 132. Global Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 133. Global Severe Asthma Treatment Sales by Application (2027-2032) & (k units) Table 134. Global Severe Asthma Treatment Sales Market Share by Application (2021-2026) Table 135. Global Severe Asthma Treatment Sales Market Share by Application (2027-2032) Table 136. Global Severe Asthma Treatment Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Severe Asthma Treatment Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Severe Asthma Treatment Revenue Market Share by Application (2021-2026) Table 139. Global Severe Asthma Treatment Revenue Market Share by Application (2027-2032) Table 140. Global Severe Asthma Treatment Price by Application (2021-2026) & (US$/unit) Table 141. Global Severe Asthma Treatment Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Severe Asthma Treatment Distributors List Table 145. Severe Asthma Treatment Customers List Table 146. Severe Asthma Treatment Industry Trends Table 147. Severe Asthma Treatment Industry Drivers Table 148. Severe Asthma Treatment Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Severe Asthma Treatment Product Image Figure 5. Global Severe Asthma Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Severe Asthma Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global Severe Asthma Treatment Sales (2021-2032) & (k units) Figure 8. Global Severe Asthma Treatment Average Price (US$/unit) & (2021-2032) Figure 9. lntravenous Product Image Figure 10. Oral Product Image Figure 11. Subcutaneous Product Image Figure 12. lnhaled Product Image Figure 13. Teenagers Product Image Figure 14. Children Product Image Figure 15. Adults Product Image Figure 16. Global Severe Asthma Treatment Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Severe Asthma Treatment, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Severe Asthma Treatment Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Severe Asthma Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Severe Asthma Treatment Sales by Region in 2025 Figure 22. Global Severe Asthma Treatment Revenue by Region in 2025 Figure 23. North America Severe Asthma Treatment Market Size by Country in 2025 Figure 24. North America Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 25. North America Severe Asthma Treatment Revenue Market Share by Country (2021-2032) Figure 26. United States Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Severe Asthma Treatment Market Size by Country in 2025 Figure 30. Europe Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 31. Europe Severe Asthma Treatment Revenue Market Share by Country (2021-2032) Figure 32. Germany Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Severe Asthma Treatment Market Size by Country in 2025 Figure 43. Asia Pacific Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Severe Asthma Treatment Revenue Market Share by Country (2021-2032) Figure 45. China Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Severe Asthma Treatment Market Size by Country in 2025 Figure 54. South America Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 55. South America Severe Asthma Treatment Revenue Market Share by Country (2021-2032) Figure 56. Brazil Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Severe Asthma Treatment Market Size by Country in 2025 Figure 60. Middle East and Africa Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Severe Asthma Treatment Revenue Market Share by Country (2021-2032) Figure 62. Egypt Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Severe Asthma Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Severe Asthma Treatment Sales Market Share by Type (2021-2032) Figure 68. Global Severe Asthma Treatment Revenue Market Share by Type (2021-2032) Figure 69. Global Severe Asthma Treatment Price (US$/unit) by Type (2021-2032) Figure 70. Global Severe Asthma Treatment Sales Market Share by Application (2021-2032) Figure 71. Global Severe Asthma Treatment Revenue Market Share by Application (2021-2032) Figure 72. Global Severe Asthma Treatment Price (US$/unit) by Application (2021-2032) Figure 73. Severe Asthma Treatment Value Chain Figure 74. Severe Asthma Treatment Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Severe Asthma Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • lntravenous
  • Oral
  • Subcutaneous
  • lnhaled
Applications
  • Teenagers
  • Children
  • Adults
Companies covered
  • Teva Pharmaceutical
  • Suzhou Connect Biopharmaceuticals
  • Sanofi
  • Novartis
  • Roche
  • GlaxoSmithKline
  • AstraZeneca
  • Regeneron Pharmaceutical
  • Pieris Pharma
  • Morphosys
  • Biosion
  • Avalo Therapeutics
  • AB Pharma
  • 4D Pharma plc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Severe Asthma Treatment Market Size (2021-2032)
  4. 2.2.2 Global Severe Asthma Treatment Sales (2021-2032)
  5. 2.2.3 Global Severe Asthma Treatment Market Average Price (2021-2032)
  6. 2.3 Severe Asthma Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 lntravenous
  9. 2.3.3 Oral
  10. 2.3.4 Subcutaneous
  11. 2.3.5 lnhaled
  12. 2.4 Severe Asthma Treatment by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Teenagers
  15. 2.4.3 Children
  16. 2.4.4 Adults
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Severe Asthma Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Severe Asthma Treatment Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Severe Asthma Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Severe Asthma Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Severe Asthma Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Severe Asthma Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Severe Asthma Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of Severe Asthma Treatment, Established Date
  9. 3.9 Global Severe Asthma Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical
  2. 4.1.1 Teva Pharmaceutical Company Information
  3. 4.1.2 Teva Pharmaceutical Business Overview
  4. 4.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Severe Asthma Treatment Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Recent Developments
  7. 4.2 Suzhou Connect Biopharmaceuticals
  8. 4.2.1 Suzhou Connect Biopharmaceuticals Company Information
  9. 4.2.2 Suzhou Connect Biopharmaceuticals Business Overview
  10. 4.2.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio
  12. 4.2.5 Suzhou Connect Biopharmaceuticals Recent Developments
  13. 4.3 Sanofi
  14. 4.3.1 Sanofi Company Information
  15. 4.3.2 Sanofi Business Overview
  16. 4.3.3 Sanofi Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi Severe Asthma Treatment Product Portfolio
  18. 4.3.5 Sanofi Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis Severe Asthma Treatment Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Roche
  26. 4.5.1 Roche Company Information
  27. 4.5.2 Roche Business Overview
  28. 4.5.3 Roche Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Roche Severe Asthma Treatment Product Portfolio
  30. 4.5.5 Roche Recent Developments
  31. 4.6 GlaxoSmithKline
  32. 4.6.1 GlaxoSmithKline Company Information
  33. 4.6.2 GlaxoSmithKline Business Overview
  34. 4.6.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline Severe Asthma Treatment Product Portfolio
  36. 4.6.5 GlaxoSmithKline Recent Developments
  37. 4.7 AstraZeneca
  38. 4.7.1 AstraZeneca Company Information
  39. 4.7.2 AstraZeneca Business Overview
  40. 4.7.3 AstraZeneca Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AstraZeneca Severe Asthma Treatment Product Portfolio
  42. 4.7.5 AstraZeneca Recent Developments
  43. 4.8 Regeneron Pharmaceutical
  44. 4.8.1 Regeneron Pharmaceutical Company Information
  45. 4.8.2 Regeneron Pharmaceutical Business Overview
  46. 4.8.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio
  48. 4.8.5 Regeneron Pharmaceutical Recent Developments
  49. 4.9 Pieris Pharma
  50. 4.9.1 Pieris Pharma Company Information
  51. 4.9.2 Pieris Pharma Business Overview
  52. 4.9.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pieris Pharma Severe Asthma Treatment Product Portfolio
  54. 4.9.5 Pieris Pharma Recent Developments
  55. 4.10 Morphosys
  56. 4.10.1 Morphosys Company Information
  57. 4.10.2 Morphosys Business Overview
  58. 4.10.3 Morphosys Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Morphosys Severe Asthma Treatment Product Portfolio
  60. 4.10.5 Morphosys Recent Developments
  61. 4.11 Biosion
  62. 4.11.1 Biosion Company Information
  63. 4.11.2 Biosion Business Overview
  64. 4.11.3 Biosion Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Biosion Severe Asthma Treatment Product Portfolio
  66. 4.11.5 Biosion Recent Developments
  67. 4.12 Avalo Therapeutics
  68. 4.12.1 Avalo Therapeutics Company Information
  69. 4.12.2 Avalo Therapeutics Business Overview
  70. 4.12.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Avalo Therapeutics Severe Asthma Treatment Product Portfolio
  72. 4.12.5 Avalo Therapeutics Recent Developments
  73. 4.13 AB Pharma
  74. 4.13.1 AB Pharma Company Information
  75. 4.13.2 AB Pharma Business Overview
  76. 4.13.3 AB Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AB Pharma Severe Asthma Treatment Product Portfolio
  78. 4.13.5 AB Pharma Recent Developments
  79. 4.14 4D Pharma plc
  80. 4.14.1 4D Pharma plc Company Information
  81. 4.14.2 4D Pharma plc Business Overview
  82. 4.14.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 4D Pharma plc Severe Asthma Treatment Product Portfolio
  84. 4.14.5 4D Pharma plc Recent Developments
5 Global Severe Asthma Treatment Market Scenario by Region
  1. 5.1 Global Severe Asthma Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Severe Asthma Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global Severe Asthma Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global Severe Asthma Treatment Sales by Region: 2027-2032
  5. 5.3 Global Severe Asthma Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global Severe Asthma Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global Severe Asthma Treatment Revenue by Region: 2027-2032
  8. 5.4 North America Severe Asthma Treatment Market Facts & Figures by Country
  9. 5.4.1 North America Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Severe Asthma Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America Severe Asthma Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Severe Asthma Treatment Market Facts & Figures by Country
  16. 5.5.1 Europe Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Severe Asthma Treatment Sales by Country (2021-2032)
  18. 5.5.3 Europe Severe Asthma Treatment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Severe Asthma Treatment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Severe Asthma Treatment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Severe Asthma Treatment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Severe Asthma Treatment Market Facts & Figures by Country
  41. 5.7.1 South America Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Severe Asthma Treatment Sales by Country (2021-2032)
  43. 5.7.3 South America Severe Asthma Treatment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Severe Asthma Treatment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Severe Asthma Treatment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Severe Asthma Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global Severe Asthma Treatment Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Severe Asthma Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Severe Asthma Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global Severe Asthma Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Severe Asthma Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Severe Asthma Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Severe Asthma Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global Severe Asthma Treatment Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Severe Asthma Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Severe Asthma Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global Severe Asthma Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Severe Asthma Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Severe Asthma Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Severe Asthma Treatment Value Chain Analysis
  2. 8.1.1 Severe Asthma Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Severe Asthma Treatment Production Mode & Process
  5. 8.2 Severe Asthma Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Severe Asthma Treatment Distributors
  8. 8.2.3 Severe Asthma Treatment Customers
9 Global Severe Asthma Treatment Analyzing Market Dynamics
  1. 9.1 Severe Asthma Treatment Industry Trends
  2. 9.2 Severe Asthma Treatment Industry Drivers
  3. 9.3 Severe Asthma Treatment Industry Opportunities and Challenges
  4. 9.4 Severe Asthma Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst